Cognitive‐behavioural treatment for amphetamine‐type stimulants (ATS)‐use disorders

Cognitive-behavioural treatment for amphetamine-type stimulants (ATS) use disorders

Background Objectives Search methods Selection criteria Data collection and analysis Main results Authors' conclusions Plain language summary [Summary title] [Summary text] Cognitive-behavioural treatment for amphetamine-type stimulants (ATS) use disorders 2 / 10 Background Description of the condition Amphetamine-type stimulants (ATS) refer to a group of synthetic stimulants including amphetam...

Olanzapine and haloperidol for the treatment of acute symptoms of mental disorders induced by amphetamine-type stimulants

BACKGROUND This study aimed to compare olanzapine and haloperidol efficacies in the treatment of acute psychiatric symptoms due to amphetamine-type stimulants (ATSs). METHODS The Zelen II design method was used; 124 patients with acute mental disorders due to amphetamine were randomly divided into olanzapine group (n = 63) and haloperidol group (n = 61). Then, a 4-week open-label medical ther...

Stimulants for paediatricians.

D oes your paediatrician have difficulty concentrating during lectures, particularly those on molecular biology and healthcare planning? When taking a history, does your paediatrician not listen properly and keep asking the same questions? Is your paediatrician too busy to spend any time with his or her own children? These are all signs of ADHD(P), a newly described phenotype of attention defic...

Stimulants, neuroleptics, and children's friendship training for children with fetal alcohol spectrum disorders.

BACKGROUND Peer relationship problems are a significant part of the clinical presentation of children with Fetal Alcohol Spectrum Disorders (FASD). Many of these children have been prescribed psychotropic medications by community practitioners. The present study reports on the interaction between medication status and parent and teacher-reported outcomes for parent-assisted Children's Friendshi...

New Hopes and Challenges for Treatment of Neurodegenerative Disorders: Great Opportunities for Young Neuroscientists